Neural Tube Defects in Uganda: Understanding the Challenges and Improving Outcomes
"A follow-up study reveals the critical need for enhanced antenatal care, coordinated treatment, and long-term support for children with neural tube defects in Uganda."
Neural tube defects (NTDs) are birth defects that occur when the neural tube, which forms the brain and spinal cord, doesn't close completely during pregnancy. These defects can lead to a range of disabilities, affecting a child’s physical and neurological development. Spina bifida, one of the most common NTDs, results in incomplete closure of the spinal cord, often causing mobility issues and other health problems.
In resource-limited settings like Uganda, the challenges associated with NTDs are magnified. Timely surgical intervention and ongoing management by specialized healthcare teams are essential, but often difficult to access. A recent study conducted at Mulago National Referral Hospital (MNRH) in Uganda sheds light on the outcomes of spina bifida patients and highlights the urgent need for improved care and support.
This article delves into the findings of the study, exploring the obstacles faced by children with NTDs in Uganda and the potential strategies to enhance their quality of life. By understanding the realities on the ground, we can work towards a brighter future for these vulnerable individuals.
U.S. Snapshot
Neural tube defects occur when the neural tube does not close properly, and the most common types are spina bifida, anencephaly, and encephalocele. The CDC reports that spina bifida affects about 1,300 babies a year in the United States. It can occur anywhere along the spine.
Diagnosis and Clinical Considerations
Spina bifida occulta may involve only the vertebral arches; BMJ Best Practice describes it as clinically insignificant and a common incidental radiologic finding, affecting 10% of the population. Open neural tube defects include open spina bifida and anencephaly, caused by incomplete neural tube closure at about four weeks of pregnancy. For fetuses with myelomeningocele or other spina bifida anomalies, fetal exome sequencing may be considered after multidisciplinary counselling and when appropriate criteria are met. Minimally invasive fetal repair techniques aim to achieve similar benefits while reducing maternal morbidity.
Historical Evidence and Care
A verified case of spina bifida has been identified in an Egyptian mummy. Texts from Babylonia may describe neural tube defects, while ancient texts from India, Greece, and Rome discuss birth defects in different contexts. The use of selection criteria in spina bifida care dates to the late 19th and early 20th centuries, when patients with neurological impairment, hydrocephalus, or major congenital anomalies were typically excluded from surgery.
What Are the Key Findings of the Uganda NTD Study?
The study, published in Neurosurgical Focus, examined the outcomes of children treated for NTDs at MNRH between 2014 and 2015. Researchers conducted follow-up phone surveys with caregivers to assess mortality rates, health issues, access to healthcare, and overall well-being. Here’s a breakdown of the key findings:
- The vast majority (92%) of the 201 patients studied were diagnosed with myelomeningocele.
- The median age at presentation was just 6 days old, highlighting the need for early detection and intervention.
- Half of the patients underwent surgical procedures, including defect closures, ventriculoperitoneal (VP) shunts for hydrocephalus, and endoscopic third ventriculostomy.
Kampala Surveillance and Fortification
A hospital-based birth-defect surveillance study in Kampala examined neural tube defect prevalence in relation to maternal HIV status and antiretroviral therapy. The study reports that Uganda passed legislation in 2011 to fortify wheat and maize flour with folic acid, iron, zinc, and other B vitamins. It also notes that compliance with the fortification legislation has been reported as variable.
The Range of Possible Effects
Neural tube defects result from incomplete closure of the neural tube along its length, which otherwise forms the brain and spinal cord. Their effects can include brain damage, hydrocephalus, learning disabilities, and difficulty swallowing. Spinal cord damage can also cause severe problems involving the bowels, bladder, and legs.
Regional Prevalence Estimates
A systematic review and meta-analysis estimated the pooled prevalence of all neural tube defects in Eastern Africa at 33.30 per 10,000 births (95% CI: 21.58 to 51.34). A separate African systematic review and meta-analysis, covering 58 studies, 16 countries, and 7,150,654 participants, estimated a pooled burden of 32.95 per 10,000 births (95% CI: 29.77–36.13). These are estimates from separate reviews with different geographic scopes, and their figures differ.
- The one-year mortality rate was alarmingly high at 34%.
- Among survivors, 91% had received healthcare since their initial discharge, but only 67% returned to MNRH for follow-up.
- Hydrocephalus was a common diagnosis, affecting 88% of patients.
- Caregivers reported physical deficits in 39% of patients, including clubfoot (18%) and bowel or bladder incontinence (12%).
- Access to home health resources was limited, with only 15% of patients reporting such access.
The Path Forward: Improving Outcomes for Children with NTDs in Uganda
The study's findings underscore the urgent need for a multi-pronged approach to improve outcomes for children with NTDs in Uganda. This includes enhancing access to quality antenatal care, ensuring timely surgical intervention, providing comprehensive follow-up care, and addressing the social stigmas associated with these conditions. By working together, healthcare professionals, policymakers, and communities can create a supportive environment where children with NTDs can thrive.
Research Directions
NICHD reports that PPB-supported researchers have validated positive outcomes of in utero surgery to repair myelomeningocele, the most severe form of spina bifida. With PPB support, researchers are also investigating techniques for diagnosing spina bifida before birth. A 2024 review discusses potential future therapeutic approaches including gene editing and regenerative medicine.